Related Experiment Video
Updated: Jul 11, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI
Masaaki Nakase1, Taishi Okuno1, Daijiro Tomii1
1Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
Insights
Cardiac damage staging accurately predicts mortality risk in patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS), regardless of AS subtype.
Area of Science:
- Cardiology
- Cardiac Surgery
- Interventional Cardiology
Background:
- Prognostic value of cardiac damage staging in severe aortic stenosis (AS) across the hemodynamic spectrum is not well-defined.
- Understanding this value is crucial for optimizing treatment strategies.
Purpose of the Study:
- To assess the prognostic impact of cardiac damage staging in patients with high-gradient AS (HG-AS) and low-gradient AS (LG-AS) undergoing transcatheter aortic valve implantation (TAVI).
Main Methods:
- Prospective evaluation of five-year mortality in a TAVI registry.
- Categorization of cardiac damage into early (stages 0-2) and advanced (stages 3-4) stages.
- Analysis across HG-AS, classical low-flow (LF) LG-AS, LF LG-AS with preserved ejection fraction (pEF), and normal-flow (NF) LG-AS subtypes.
Main Results:
- The study included 2,090 patients undergoing TAVI.
- Advanced cardiac damage was more prevalent in classical LF LG-AS (73.6%) compared to other subtypes.
- Advanced cardiac damage was consistently associated with significantly higher five-year mortality across all AS subtypes after TAVI (adjusted HRs ranging from 1.49 to 1.69).
Conclusions:
- Cardiac damage staging classifications effectively stratify mortality risk following TAVI.
- This stratification is valid irrespective of the specific subtype of severe aortic stenosis.
Background:
The prognostic value of cardiac damage staging classifications across the haemodynamic spectrum of severe aortic stenosis (AS) remains unknown.
Aims:
We aimed to investigate the prognostic impact of cardiac damage staging classifications in patients with high-gradient AS (HG-AS) and low-gradient AS (LG-AS) undergoing transcatheter aortic valve implantation (TAVI).
Methods:
In a prospective TAVI registry, five-year mortality was evaluated for early stages of cardiac damage (stage 0, 1, or 2) and advanced stages of cardiac damage (stage 3 or 4) in patients with HG-AS, classical low-flow (LF) LG-AS, LF LG-AS with preserved ejection fraction (pEF), and normal-flow (NF) LG-AS.
Results:
Among 2,090 patients undergoing TAVI, 1,045 patients had HG-AS, 337 patients had classical LF LG-AS, 394 patients had LF LG-AS with pEF, and 314 patients had NF LG-AS. The majority of patients with classical LF LG-AS exhibited advanced cardiac damage (73.6%), followed by LF LG-AS with pEF (55.6%), NF LG-AS (51.6%), and HG-AS (50.6%). Patients with advanced stage cardiac damage had significantly higher mortality after TAVI than those with early stage cardiac damage in all subtypes of AS (adjusted hazard ratio [HRadjusted] 1.66, 95% confidence interval [CI]: 1.34-2.06 for HG-AS; HRadjusted 1.49, 95% CI: 1.02-2.16 for classical LF LG-AS; HRadjusted 1.69, 95% CI: 1.22-2.35 for LF LG-AS with pEF; and HRadjusted 1.52, 95% CI: 1.04-2.32 for NF LG-AS).
Conclusions:
Cardiac damage staging classifications stratified mortality after TAVI irrespective of AS subtype.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care

